✦ LIBER ✦

Controversies: Recurrent squamous cell carcinoma of the true vocal cord

✍ Scribed by Dr. Dale H. Rice; Dr. Stephen J. Wetmore; Dr. Mark Singer

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 348 KB
Volume: 13
Category: Article
ISSN: 1043-3074
DOI: 10.1002/hed.2880130613

No coin nor oath required. For personal study only.

✦ Synopsis

A T ~N O

squamous cell carcinoma of the true vocal cord is rarely a controversial lesion. In fact, this is a lesion about which surgeons and radiotherapy therapists usually agree, and radiotherapy is usually the treatment of choice. However, when a lesion fails conventional treatment not everyone agrees on how to proceed. Therein lies the controversy in this case.

A 69-year-old man is initially seen by you with hoarseness and a squamous cell carcinoma of the free edge of the left true vocal cord. You suspect that it may involve a portion of the undersurface of the cord. There is no subglottic extension. The anterior commissure is uninvolved. The tumor extends back to but does not involve the arytenoid. The cord is mobile. The remainder of the examination is unremarkable. You stage this lesion as TlNO.

This lesion is treated with radiotherapy. The total dose is 66 Gy. The patient does well and is good about follow-up. Two years later a rough spot is seen in the area of the original tumor. He

📜 SIMILAR VOLUMES

Controversies. T1 squamous cell carcinom

Controversies. T1 squamous cell carcinoma of the true vocal cord

✍ Snyderman, Nancy L. ;Marks, Richard ;Clark, Keith ;Wetmore, Stephen J. 📂 Article 📅 1988 🏛 Wiley (John Wiley & Sons) ⚖ 209 KB 👁 1 views

T h e diversified armamentarium for treating T1 carcinomas of the glottis has led most head and neck surgeons to expect high cure rates. Yet controversy persists. Concern centers around which modality is most straightforward and which offers the best posttreatment voice. With new "conservative" form

Radiotherapy for carcinoma in situ of th

Radiotherapy for carcinoma in situ of the true vocal cords

✍ Allie Garcia-Serra; Russell W. Hinerman; Robert J. Amdur; Christopher G. Morris; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

## Abstract ## Purpose To report long‐term rates of tumor control after radiotherapy (RT) for carcinoma in situ (CIS) of the true vocal cords (TVC). A comprehensive literature review was performed, and outcomes with other modalities of treatment for CIS of the TVC were compared. ## Materials and

Recurrent squamous cell carcinoma of the

Recurrent squamous cell carcinoma of the skin

✍ Steven C. Immerman; Edward F. Scanlon; Miriam Christ; Kerry L. Knox 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB 👁 3 views

Recurrent squamous cell carcinoma of the

Recurrent squamous cell carcinoma of the lower lip

✍ Mary Fazekas-May; Michael Sullivan; Sharon Collins 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB

Early carcinomas of the lip are usually straightforward in their management and outcome. The exceptions can result in severe morbidity. A 32-year-old man underwent a V-lip excision for a T1 squamous cell carcinoma of the left lower lip 2 years ago. All margins were free of tumor. He has had irregul

Controversies in the management of advan

Controversies in the management of advanced laryngeal squamous cell carcinoma

✍ Randal S. Weber; Arlene Forastiere; David I. Rosenthal; Ollivier Laccourreye 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

The current treatment paradigm for patients with advanced laryngeal squamous cell carcinoma continues to evolve. The authors assembled a panel of experts from the fields of medical oncology, radiation oncology, and surgery to discuss treatment options and to defend their positions.

Salvage treatment for recurrent squamous

Salvage treatment for recurrent squamous cell carcinoma of the oral cavity

✍ Glenn J. Schwartz; Rajeev H. Mehta; Barry L. Wenig; Chitra Shaligram; Louis G. P 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

Background. Squamous cell carcinoma (SCCA) of the oral cavity recurs with a frequency of 25%-48%, a fact that usually portends a poor prognosis. Recent studies have reported salvage cure rates as high as 67%. Investigators have also claimed that restaging recurrent tumors provides useful prognostic